VR Logo

CorMedix Inc. (CRMD) download report


Healthcare | Biotechnology & Pharma Research

CorMedix Inc. (CRMD) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally.

IPO Date: 25-Mar-2010

Exec. VP & CFO: Dr. Matthew T. David M.D.

Exec. VP & Gen. Counsel: Dr. Phoebe Mounts Esq.

Listing: NASDAQ: CRMD

Country: United States

Headquarters: Berkeley Heights, NJ

Website: https://www.cormedix.com

Key Facts

Market cap: $134.98 Mln

Revenue (TTM): $0.11 Mln

Earnings (TTM): $-28.03 Mln

Cash: $61.69 Mln

Total Debt: $0.89 Mln

Insider's Holding: 1.71%

Liquidity: Low

52 Week range: $2.65 - 7.70

Shares outstanding: 39,123,300

10 Years Aggregate:

  • CFO: $-157.47 Mln
  • EBITDA: $-194.98 Mln
  • Net Profit: $-202.35 Mln

Stock Performance

Time Period CorMedix (CRMD) S&P BSE Sensex S&P Small-Cap 600
YTD-24.84-8.71-17.92
1 month10.32-3.11-7.88
3 months-43.56-7.30-13.56
1 Year-56.760.48-17.16
3 Years-23.1710.346.95
5 Years7.9011.436.30
10 Years11.4912.1010.29
As on 28-Jun-2022
Year CorMedix (CRMD) S&P Small-Cap 600 S&P BSE Sensex
2021-38.7625.2721.99
20202.069.5715.75
201912.8720.8614.38
2018155.65-9.705.87
2017-67.1911.7327.91
2016-24.6324.741.95
20156.28-3.36-5.03